Vita Longa was founded in September 2014.
Our aim is to make available to the Greek patients a range of novel super-generic drugs, meaning already well-established and efficient active ingredients formulated in innovative, improved pharmaceutical preparations, in order to enhance the patient’s quality of life.
Active ingredients that have already been widely administered to millions of patients worldwide, and with already proven efficacy and safety, are made available through novel pharmaceutical preparations, adapted to the recent therapeutic protocols and suitable to specific groups of patients.
For the development, manufacturing and distribution of our products, Vita Longa has selected an outstanding, reliable group of Greek partners, fully certified according to the international guideline/regulation systems.
